TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,051 | -65.9% | 963 | +1.4% | 0.00% | – |
| Q2 2023 | $23,598 | +65.2% | 950 | 0.0% | 0.00% | – |
| Q1 2023 | $14,288 | +1107.8% | 950 | +850.0% | 0.00% | – |
| Q4 2022 | $1,183 | +18.3% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 100 | +61.3% | 0.00% | – |
| Q4 2018 | $0 | – | 62 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 62 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 62 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 62 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 62 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 62 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |